Volume 5: No.
2, April 2008
COMMUNITY CASE STUDY
Strategies for Controlling Blood Pressure Among Low-Income Populations in Georgia
Roberta Constantine, PhD, J. Nell Brownstein, PhD, Sonja Hoover, MPP, Lashawn Wordlaw-Stinson, PhD, Diane Orenstein, PhD, Patricia Jones, RN, CDE, Rosanne Farris, PhD
Suggested citation for this article: Constantine R, Brownstein JN, Hoover S, Wordlaw-Stinson L, Orenstein D, Jones P, et al.
Strategies for controlling blood pressure among low-income populations in
Georgia. Prev Chronic Dis 2008;5(2).
apr/07_0200.htm. Accessed [date].
In Georgia an estimated 32% of blacks and 28% of whites have high blood pressure. In 2004 the
rate of death from stroke in Georgia was 12% higher than the national average, and blacks in the state have
a 1.4 times greater rate of death from stroke than that of whites.
The Georgia legislature funds the Stroke and Heart Attack Prevention Program (SHAPP) to provide treatment and medications for indigent Georgians. The median rate of blood pressure (BP) control among SHAPP enrollees is approximately 60%, compared with the national average of 35%.
SHAPP was evaluated through interviews with key health care and administrative staff and through focus groups of patients in two clinics.
Outcomes for patients were increased knowledge of their BP and improved compliance with taking medication and keeping clinic appointments.
Successful components of SHAPP include an easy enrollment process; affordable medication; use of evidence-based, documented protocols and patient tracking systems; routine follow-up of patients; and effective communication between staff and patients. Challenges and recommendations for improvement are identified.
Back to top
In the United States high blood pressure (HBP), or hypertension (HTN), is of great concern because of its widespread prevalence and its impact on the incidence of heart disease and stroke (1). Nationally, nearly one-third of adults have HTN (mean systolic BP ≥140 mm Hg or mean diastolic BP ≥90 mm Hg, based on two measurements taken at least 2 minutes apart), and another 28% have prehypertension (BP of 120–139 mm Hg [systolic] and/or 80–89 mm Hg [diastolic]) (1). Nearly
70% of people with HTN do not have it under control (1,2). HTN is particularly common among blacks, who have a 30% higher prevalence than whites (3). Compared with whites, blacks develop HTN earlier in life, have higher average BP, and have higher rates of complications from HTN, such as stroke, heart attack, and end-stage renal disease (2,4-5). Prevalence of HTN is higher in the southeastern states than in other U.S. states and is higher among blacks than among whites (5). Lifestyle
changes recommended for controlling HTN include maintaining a healthy weight, stopping smoking, maintaining a healthy diet, and engaging in regular physical activity (6). For some patients, antihypertensive medications may be indicated, and adherence to treatment is essential.
In Georgia an estimated 32% of blacks and 28% of whites have HTN (6,7). In 2004 the
rate of death from stroke in Georgia was 12% higher than the national average
(7), and the burden of stroke is especially heavy for the state’s black
population. Blacks in the state have a 1.4 times greater rate of death from
stroke than that of whites (8); these disparities might be related to differences in risk factors among blacks and whites, lower socioeconomic and
educational status among blacks, cultural dietary practices of blacks, and blacks’ poor access to treatment for chronic disease (4,9). The trends in Georgia are similar to the trends
in other southeastern states (9).
Back to top
In 1974 the Georgia legislature founded the Stroke and Heart Attack Prevention Program (SHAPP), an education and direct-service program targeting low-income Georgians with HBP. To be eligible, patients must be 18 years of age or older, have proof of income not to exceed 200% of the current federal poverty guidelines, and have proof of having no prescription drug benefits (patients who need only education and monitoring do not have to meet eligibility requirements). More than 1.1 million
Georgians, or more than 13% of the population, are below the federal poverty level, and poverty is associated with poor control of HBP, diabetes, and other chronic conditions (10).
SHAPP serves 16 of Georgia’s 18 public health districts. Patient services,
provided through county health departments and one independent contractor,
include screenings, referral to doctors, diagnosis, treatment, and follow-up.
Patients can refer themselves to SHAPP, or they can be referred by a physician.
Treatment protocols are based on recommendations of the Joint National Committee
on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (2).
Through SHAPP, indigent adults with medical conditions are eligible for HTN medications at low or no cost and to have treatment outcomes monitored.
Physicians are available for consultation to people with complications or
problems. The clinics use tracking systems for appointments and for monitoring
patient status, and public health nurses, serving as case managers, monitor
patients for problems, keeping appointments, and adherence to taking medications
(11). SHAPP also provides patient, professional, and public education.
Although almost half a million people in Georgia could be eligible for SHAPP, fewer than 16,000 patients were served in 2003 (11). The number of patients served is limited because of funding restrictions. The largest population segments served include blacks and people aged 30–59 years. Rates of controlling HTN range from 38% to 84% among Georgia’s public health districts (6); the median rate among Georgia public health districts is approximately 60% (11).
We report the outcome of an evaluation using interviews with SHAPP staff and
focus groups with patients enrolled in SHAPP to determine the factors contributing to successful control of HTN.
The study involved SHAPP in two clinics, one in Georgia’s east central public health district and another in Georgia’s
coastal public health district. The data gathered through these qualitative methodologies proved to be a rich source of information and provided insights about the
successful HTN control rates in the two clinics. A cost-effectiveness evaluation of the two clinics estimated enhanced patient health, decreased adverse events, and reduced costs to the state; these results are published elsewhere (11).
Back to top
Selection of districts
We selected the east central and coastal public health districts for several reasons, including the districts’ successful rates of BP control, sufficient cost data on patient and pharmaceuticals, use of two different patient tracking systems, and geographic and demographic diversity (9). In 2003 the
east central district reported a BP control rate of 64%, and the coastal district reported 60%. The
east central district served 543 SHAPP patients in 13 counties through 15 clinics, and the
coastal district served 1632 SHAPP patients in 13 counties through 14 clinics (SHAPP annual performance report 2003, unpublished data). Clinic 1 (31 patients), in the
east central district, and Clinic 2 (125 patients), in the coastal district, were selected for the focus groups.
Interviews and focus groups
Four telephone interviews and one focus group were conducted in each
district. Administrative staff, nurses, and physicians participated in telephone
interviews. Clinic staff, who had established relationships with the patients
and were able to facilitate the process, recruited patients (who had been in
SHAPP for at least 6 months) for the focus groups. Each focus group had six patients: three with uncontrolled HBP (mean systolic BP ≥140 mm Hg or mean diastolic BP ≥90 mm
Hg, based on two measurements taken at least 2 minutes apart) and three with controlled HBP.
A gratuity ($15) was provided to participating patients; the focus groups lasted
approximately 90 minutes.
Interviews with SHAPP administrators and clinic staff examined the program’s challenges, patient access to the program, patient outcomes, and recommendations for improvement. The focus groups covered perceptions of the program, experiences with HBP, effects of participation, access to the program, and recommendations.
Institutional review board approval was obtained from the Centers for Disease Control and Prevention, Research Triangle Institute (RTI),
and the Georgia Department of Human Resources. Before conducting the focus
groups, informed consent was explained to participants, and the consent form was
reviewed with the participants and signed.
Both the interviews and the focus groups were conducted by a two-person team from RTI,
using the success case method for qualitative evaluation (12). The team
identified subtopics for following up on potential responses, a process designed to ensure that all critical issues were addressed. The interviews and focus groups were conducted in February and March of 2005.
After each interview and each focus group, the research team held a debriefing session in which notes they had taken were
integrated; this strategy provides context for understanding the responses and conceptualizes the data in terms of the study objectives. The themes were grouped and analyzed using the qualitative software ATLAS 5.0 (ATLAS.ti Scientific Software Development GmBH, Berlin, Germany).
Back to top
SHAPP staff identified two key challenges with the program: 1) funding and staff levels, and 2) patient care and treatment. Key challenges and components of success identified by staff are summarized in the
Funding and staff
Funding challenges posed the most immediate threat to keeping the program in operation. All of the staff emphasized the negative impact
of state budget cuts on recruiting staff, enrolling patients, and obtaining HBP medications.
These funding cuts affected the hiring and retention of nursing staff. One
staff member stated that 75% of newly hired nurses within all the health
districts quit within 6 months for better pay or more reasonable caseloads
elsewhere. The SHAPP caseload was high at any given time, because only two nurses managed SHAPP
patients and coordinated SHAPP and other patients in each clinic. Despite the staff shortage,
focus group participants described interactions with the clinic staff positively.
Patient care and treatment
The staff found working with the client population to modify their lifestyle behaviors (i.e., diet, physical activity, smoking, alcohol consumption) an ongoing challenge, because many patients were reluctant to significantly change their lifestyles.
Often the patients presented with comorbidities (e.g., diabetes). However,
because SHAPP is uniquely designed to address primary HTN, patients who required other medications needed to seek care elsewhere for those conditions. Many patients did not have any other access to health care or funds for medications.
Components of success
The staff identified several components of SHAPP that were critical to patients’ success in lowering BP:
Staff commitment to patient care and belief in the value of SHAPP for the community.
The staff indicated that SHAPP fills a critical need for indigent community members.
Effective communication between providers and patients. SHAPP was successful in managing HTN,
as judged by BP control rates. Control rates for SHAPP enrollees were 60% and
64% in the two districts, compared with a 35% control rate nationally. Increased control rates among SHAPP enrollees were accomplished through monitoring, counseling, and compliance with medication. Staff spoke with patients whose HTN
was resistant to treatment to learn whether nonadherence to
lifestyle recommendations, noncompliance with medications, or changes in medication dosage or drug type were the cause.
Support for patients and families. The nurses provided counseling and education, built skills, and recruited parents or caregivers to support patients in complying with treatment.
Available and affordable medications. SHAPP filled a need in the community by supplying most of the patients (90%–98%) with medications to help control their BP. The staff believed that patients would have difficulty in obtaining affordable medications elsewhere.
Ongoing tracking and monitoring system (including system reminders) to maintain continuity of care. Nurses provided counseling to emphasize the importance of keeping appointments. In one of the clinics, clients were telephoned the day before the appointment or, if the appointment was missed, later that day. The nurses followed up missed appointments with letters. The other clinic used a computerized tracking and monitoring system, which provided nurses with a computer printout of an
active patient list so patients could be screened for attendance and BP control.
Patients identified four program elements that were critical to success in BP
control: ease of enrollment, staff commitment, affordable medications, and
education about lifestyle modifications. Elements of SHAPP that patients identified as critical to their success in controlling
HTN are summarized in the Table.
Ease of enrollment
Because knowledge of SHAPP was obtained generally by word of mouth,
self-referral was as common as a referral from a physician or local health
department. Participants believed that enrollment was easy. As one focus group participant stated: “It wasn’t hard. I mean, you’d give them all the information they need.” Participants also appreciated the staff’s professionalism: “They didn’t make you feel embarrassed or anything — that you were, you know, poverty level.” The patients were only turned away if they were not income eligible or if they already had other insurance (i.e., Medicaid). However, ineligibility was
rarely a problem, because the program was structured to target people not
reached by the health care system.
Staff commitment to and communication with patients
Focus group participants clearly indicated that the caring SHAPP staff exceeded their expectations. They described the staff as “real nice, real good,” “helpful,” and even “if you don’t lose but a pound, they just make you feel good.” As one participant stated, “They’re helpful in all ways and they make time for you.” It was a significant benefit to the patients to have staff available to provide counsel and support for lifestyle modifications and compliance with
Participants mentioned that when the “appointment’s maybe a little past,” nurses tried to reschedule them or counseled them over the phone. When asked about being seen in the clinic, another participant responded: “Every 3 months, I think it is. That’s the way it is with me. They set it up. Or if I need to come earlier or something . . . just call them and they’ll know you, they’ll probably set you up earlier.”
Availability of affordable medications
Participants indicated the program had helped them immeasurably in being
able to afford medications. One stated, “. . . [I]f it hadn’t been for the
program, I’d be dead right now . . . because I couldn’t afford the medicine,”
and another said, “[I]f it wasn’t for this program, we couldn’t make it.”
According to the participants, SHAPP succeeded in its goal of providing
affordable HBP medications. Before enrolling, many of the participants said
they could not afford their BP medications and other medications. However, after enrolling the participants were all able to afford their BP medications and expressed thanks for the program.
Education about lifestyle modifications
Focus group participants and staff who were interviewed generally agreed that
the program was effective in lowering BP. Focus group participants indicated
that it was an ongoing effort to learn how to control their BP but that SHAPP
gave them the tools they needed. When asked what they had learned through SHAPP that they did not learn from their physicians, one respondent answered, “To try to control [my BP] . . . well, eat the right foods. . . . The medication helps a lot, too."
Back to top
Overall, the clinics confronted the same challenges in keeping SHAPP in operation and successful. From the interviews, we found that the most common patient outcomes were improvements in knowledge of HTN, compliance with medications, and keeping appointments. This is consistent with outcomes of other community-based studies (9,13).
Through the interviews and focus groups, four themes emerged that explained
much of the success of the two clinics: program access, staff dedication,
continuity of care, and patient satisfaction. The patients found that the staff
made time for them, were accepting and nonjudgmental of their low-income status,
and treated them well. The staff were dedicated and consistently voiced the
opinion that SHAPP filled a need in the community; they understood the
importance of their work and that the patients would be unlikely to receive care
otherwise. The patients also expressed this theme; without SHAPP their HTN would not be addressed. The satisfaction expressed by the patients suggests that their expectations of care and requests for medicine were met and that they trusted the staff.
Their high level of adherence to HBP treatment reflected their satisfaction.
Both clinics worked with the patient population to modify lifestyle behaviors, which was an ongoing challenge. Interestingly, in another qualitative study of 93 blacks (mostly low-income and female) with
HTN, many of the patients believed that if they took their medications as prescribed they would not have to adopt healthier lifestyles (14). Some SHAPP patients may have shared this belief, which might help to explain the source of the nurses’ frustrations with the lack of
significant lifestyle modifications in the patient population.
Many of the critical components for success identified in this case study
also were found in population-based randomized controlled trials (on HTN) and other BP control studies testing community health workers (CHWs) as members of health care delivery teams. Many of these studies developed strong community partnerships, provided medications, and, through nurse-supervised CHWs, provided education, counseling, skill building, and continuity of care through monitoring and tracking,
including appointment reminders (13). Other nurse-based HTN interventions also have resulted in successful BP outcomes (13,15,16). SHAPP nurses provided continuing education based on the traditional medical model that HTN is a chronic, largely asymptomatic, incurable condition that requires lifelong compliance with treatment (2). The HTN
control rate of the two clinics would indicate that most of the patients
understood this model. SHAPP is based on the Chronic Care Model, which
involves patients in their own care (17). Thus, these high-performing clinics
have translated, adopted, and implemented evidence-based research findings into
everyday practice. One strategy that might aid the nurses in SHAPP programs is to recruit, train, and integrate CHWs into the care team. Supervised by nurses, CHWs
can provide health education, counseling, and tracking of patients (13),
reducing the burden on nurses and possibly allowing for more participants in SHAPP.
The staff offered several ideas for improving SHAPP in the areas of outreach and primary prevention:
Outreach. Link SHAPP patients and the community at large to resources to support healthy lifestyle habits, identify at-risk people, and acquire a mobile clinic unit.
Prevention. Ideas included the following: 1) work collaboratively with other state-supported programs for prevention and treatment; 2) enhance or strengthen existing services (examples included adding more nursing staff and an on-site physician and hiring at competitive salaries, particularly nurse practitioners for their specialized training); 3) provide nursing staff with specialized training in cardiovascular medicine; and 4) expand SHAPP funding and staff to meet the challenges of
patients with comorbid conditions. If patients are given coordinated treatment for health problems related to cardiovascular disease, the results will include improved patient health and more cost-effective operations.
Sustainability. Provide stable legislatively proportionate funding so
adequate staff can be recruited and retained. The staff were passionate in
their views that SHAPP fulfilled a need in the community and the community would witness an increase in uncontrolled HTN, an increase in hospitalizations from complications of HBP, and, within a 5-year period, an increase in overall mortality rates from heart attack if SHAPP
was discontinued. The staff expressed concern that without SHAPP, patients would not
self-manage their HBP.
Additionally, given the estimated cost savings, improved patient outcomes,
and fewer expected adverse events, we suggest that other states should consider
and test the promising practice
demonstrated by SHAPP (8). If indigent people do not receive education and services for treatment of their HTN, adverse events, higher rates of death, and overwhelming medical and societal costs
will increase substantially. An earnest and ongoing commitment by the federal and
state governments and others is required to provide sustainable funding and adequate manpower to provide HTN education and services.
Our study had a few limitations. We examined SHAPP in only two clinics, because conducting a case study of most or even all of the clinics would have been too costly. The two clinics we studied were not selected randomly, and the results are not generalizable nationally or within the state. These limitations notwithstanding, exploring promising programs in the field will provide insight into what works for patients and
will help to move public health practice forward.
Back to top
RTI acknowledges the contribution of the Georgia Department of Human Resources, the Stroke and Heart Attack Prevention Program, Virginia Bradshaw, Joanne Burnsed, Betty Dixon, Kenneth Holiness, Dr Kristen Mertz, John Nolan, Tracy Vaught, Jodi Reece, and Carol Usry. RTI also thanks Pat Jones, Mary Jo Fina, and Linda Johnson. This project was funded by the Centers for Disease Control and Prevention under contract No. 500-00-1234. Research Triangle Institute assumes responsibility for the
accuracy and completeness of the information contained in this report.
Back to top
Corresponding Author: J. Nell Brownstein, PhD, Centers for Disease Control and Prevention, Division for
the Prevention of Heart Disease and Stroke, 4770 Buford Highway, NE, Mailstop K-47, Atlanta, GA, 30341-3717. Telephone: 770-488-2570. E-mail: firstname.lastname@example.org.
Author Affiliations: Roberta Constantine, Sonja Hoover, Lashawn Wordlaw-Stinson, Research Triangle Institute, Waltham, Massachusetts; Diane Orenstein, Rosanne Farris, Division for the Prevention of Heart Disease and Stroke, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; Patricia Jones,
Stroke and Heart Attack Prevention Program, Georgia Department of Human Resources, Atlanta, Georgia.
Back to top
- Heart disease and stroke statistics — 2007 update. Dallas (TX): American Heart Association;
2007. http://www.americanheart.org/downloadable/heart/ 1166711577754HS_StatsInsideText.pdf.* Accessed
August 20, 2007.
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al.
seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289(19):2560–72.
- Hajjar I, Kotchen TA.
Trends in prevalence, awareness, treatment, and control hypertension in the United States, 1988-2000. JAMA 2003;290(2):199–206.
- Centers for Disease Control and Prevention.
Disparities in deaths from stroke among persons aged <75 years — United
States, 2002. MMWR Morb Mortal Wkly Rep 2005;54(19):477-81.
- Centers for Disease Control and Prevention.
Regional and racial differences in prevalence of stroke — 23 states and District of Columbia, 2003. MMWR Morb Mortal Wkly Rep 2005;54(19):481–4.
- 2006 Georgia program and data summary: cardiovascular disease. Publication
no. DPH06.127HW. Atlanta (GA): Georgia Department of Human Resources,
Division of Public Health, and the American Heart Association, Southeast
Affiliate; 2006. http://www.health.state.ga.us/pdfs/epi/cdiee/CDIEE%20Data%20Summaries%202006/2006%20CVD%20Program%20+%20Data%20Summary.pdf.* Accessed August 21, 2007.
- Behavioral Risk Factor Surveillance System, 2005. Atlanta (GA): Centers
for Disease Control and Prevention. http://www.cdc.gov/brfss/. Accessed August 20, 2007.
- Georgia Division of Public Health. Cardiovascular Health — Stroke and Heart Attack Prevention Program (SHAPP). http://www.health.state.ga.us/epi/cdiee/cardio.asp.* Accessed August 21, 2006.
- Hajjar I, Kotchen T.
Regional variations of blood pressure in the United States are associated with regional variations in dietary intakes: the NHANES-III data. J Nutr
- U.S. Census Bureau. State and county quickfacts, Georgia. Washington (DC):
U.S. Census Bureau, Housing and Household Economic Statistics Division,
Small Area Estimates Branch.
http://quickfacts.census.gov/qfd/states/13000.html. Accessed January 9,
- Rein DB, Constantine RT, Orenstein D, Chen H, Jones P, Brownstein JN, et
al. A cost evaluation of the Georgia Stroke and Heart Attack Prevention
Program. Prev Chronic Dis 2006;3(1).
http://www.cdc.gov/pcd/issues/2006/jan/05_0143.htm. Accessed August 20,
- Brinkerhoff RO. The success case method. San Francisco (CA): Berrett-Koehler Publisher, Inc; 2003.
- Brownstein JN, Chowdhury FM, Norris SL, Horsley T, Jack L Jr, Zhang X, et al.
Effectiveness of community health workers in the care of people with
hypertension. Am J Prev Med 2007;32(5):435-47.
- Ogedegbe G, Mancuso CA, Allengrante JP.
Expectations of blood pressure management in hypertensive African-American patients: a qualitative study. J Natl Med Assoc 2004;96(4):442–9.
- Garcia-Pena C, Thorogood M, Armstrong B, Reyes-Frausto S, Munoz O.
Pragmatic randomized trial of home visits by a nurse to elderly people with hypertension in Mexico. Int J Epidemiol 2001;30(6):1485-91.
- New JP, Mason JM, Freemantle N, Teasdale S, Wong LM, Bruce NJ, et al.
Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT): a randomized controlled trial. Diabetes Care 2003;26(8):2250–5.
- Wagner EH.
Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1998;1(1):2-4.
Back to top